More Business Wire
View Older Stories View Newer Stories-
Boston Pharmaceuticals Presents Data at NASH-TAG 2024 Demonstrating Low Immunogenicity Over Time With Long-acting FGF21 Analogue, BOS-580, for MASH
-
OneSpan Inc. Announces Leadership Change
-
Continental and Aurora Finalize Design of World’s First Scalable Autonomous Trucking System
-
Robert Denton Elected as Chairman of the Board of Trustees
-
Coya Therapeutics Announces Successful Pre-IND and Type C Meetings with the FDA to Advance the Development of COYA 302 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
-
A10 Networks to Announce Fourth Quarter and Full Year 2023 Financial Results on February 6, 2024
-
Twist Bioscience Appoints Adam Laponis as Chief Financial Officer
-
Cardurion Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
-
Paragon 28 Advances Foot and Ankle Specific Soft Tissue Portfolio with Launch of Grappler® Knotless Anchor System and Innovative Bridgeline™ Tape
-
Nimbus Therapeutics Announces Expansion of Its Immunology Drug Discovery Pipeline
-
Leavitt Equity Partners Closes $180 Million Fund III, Surpassing $150 Million Target
-
Heliogen’s CEO to Lead Public Presentation in Sidoti’s Virtual Investor Conference
-
Janus Henderson to Report Fourth Quarter and Full-Year 2023 Results
-
Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH
-
New research highlights the positive impact of GLP-1s and other anti-obesity medications on the Allurion Program
-
FHLBank Pittsburgh Announces 2024 Board Leadership
-
Evercore ISI to Host 10th Annual Utility CEO Conference, January 11-12, 2024
-
Digimarc to Present at 26th Annual Needham Growth Conference
-
Kenvue to Announce Fourth Quarter and Full Year 2023 Results on February 8, 2024
-
Wells Fargo to Announce Fourth Quarter 2023 Earnings on Jan. 12, 2024
-
MAIA Biotechnology to Present at Biotech Showcase 2024 on January 9, 2024
-
Advance Auto Parts Names Elizabeth Dreyer Chief Accounting Officer
-
Byline Bancorp, Inc. to Announce Fourth Quarter 2023 Financial Results on Thursday, January 25
-
Gannett to Present at the 26th Annual Needham Growth Conference
-
Ingersoll Rand Schedules Fourth Quarter 2023 Earnings Release and Conference Call
-
AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
-
Deciphera Pharmaceuticals Announces Nature Medicine Publication of Results from Exploratory ctDNA Analysis from INTRIGUE Phase 3 Study Demonstrating Substantial Clinical Benefit of QINLOCK® in 2L GIS
-
Marti Announces Completion of Redemption of Outstanding Warrants
-
Neurogene Announces Business Update and 2024 Outlook
-
Boxlight Corporation Board of Directors Announces Leadership Changes
-
SimBioSys® Elevates Leadership Team as It Receives First FDA Clearance for Digital Precision Medicine Platform, TumorSight™
-
CI Global Asset Management Announces Confirmed Annual Reinvested Distributions for JFT Strategies Fund
-
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Green Plains Inc. and Green Plains Partners LP Announce Unitholder Approval of Merger
-
Genesco Names Chris Santaella as Executive Vice President and Chief Merchandising Officer of Journeys Group
-
Savers Value Village, Inc. Announces Preliminary Fourth Quarter and Full Year Net Sales and Participation in the ICR Conference
-
Merck Announces Phase 3 Trial Initiations for Four Investigational Candidates From its Promising Hematology and Oncology Pipeline
-
Kinsale Capital Group Announces Board and Management Changes
-
Core Scientific Announces December and Full Year 2023 Production and Operations Updates
-
agilon health Announces Tim Bensley to Retire as CFO
-
Banc of California Announces Schedule of Fourth Quarter 2023 Earnings Release and Conference Call
-
Essential Utilities Recognized on Newsweek’s Most Responsible Companies List for Third Consecutive Year
-
WiSA Technologies to Host CES Investor Open House on January 10th, 6:00 pm PT
-
Omniose Announces Scientific Collaboration With AstraZeneca to Research Vaccines for Serious Bacterial Diseases
-
Aurinia Provides Preliminary Unaudited Fourth Quarter and Full-Year 2023 Net Revenue Results
-
New Bell & Spigot Pipe Solution from Contech Engineered Solutions Eases Installation
-
agilon health Provides 2023 Guidance Update, Initial 2024 View
-
Delta-Fly Pharma Inc.: Update on the R&D status of DFP-10917 and DFP-14927, a novel PEG Drug Conjugate, in the patients with R/R AML
-
Thomas Park Launches New Construction Services
-
Tikehau Capital: Disclosure of Shares Repurchases From 29 December 2023 to 04 January 2024
